Stay Ahead of Compliance with Monthly Citation Updates


In your State Survey window and need a snapshot of your risks?

Survey Preparedness Report

One Time Fee
$79
  • Last 12 months of citation data in one tailored report
  • Pinpoint the tags driving penalties in facilities like yours
  • Jump to regulations and pathways used by surveyors
  • Access to your report within 2 hours of purchase
  • Easily share it with your team - no registration needed
Get Your Report Now →

Monthly citation updates straight to your inbox for ongoing preparation?

Monthly Citation Reports

$18.90 per month
  • Latest citation updates delivered monthly to your email
  • Citations organized by compliance areas
  • Shared automatically with your team, by area
  • Customizable for your state(s) of interest
  • Direct links to CMS documentation relevant parts
Learn more →

Save Hours of Work with AI-Powered Plan of Correction Writer


One-Time Fee

$49 per Plan of Correction
Volume discounts available – save up to 20%
  • Quickly search for approved POC from other facilities
  • Instant access
  • Intuitive interface
  • No recurring fees
  • Save hours of work
F0757
D

Failure to Ensure Unnecessary Drug Use Was Avoided for Anticoagulant Therapy

Cicero, Illinois Survey Completed on 06-06-2025

Penalty

No penalty information released
tooltip icon
The penalty, as released by CMS, applies to the entire inspection this citation is part of, covering all citations and f-tags issued, not just this specific f-tag. For the complete original report, please refer to the 'Details' section.

Summary

A resident with multiple diagnoses, including unspecified dementia, bipolar disorder, schizoaffective disorder, and other chronic conditions, was found to be receiving heparin injections for VTE (venous thromboembolism) prophylaxis. The physician order sheet indicated that the resident was to receive heparin 5000 units subcutaneously every eight hours, and the medication administration record confirmed that the resident received this medication multiple times in June. However, a review of the resident's medical diagnoses and the Minimum Data Set (MDS) revealed no documented diagnosis of VTE or any other condition justifying the use of heparin. During interviews, the medical doctor stated that the resident was on heparin because it was started in the hospital and to prevent blood clots, particularly in non-ambulatory patients. However, the resident was observed to be ambulatory and able to transfer independently. The administrator confirmed that there was no current diagnosis supporting the use of heparin for this resident, and documentation from a nurse practitioner visit also did not provide a diagnosis for the continued use of the anticoagulant.

An unhandled error has occurred. Reload 🗙